Answers are grounded in this paper and cite their sources.
Alzheimer''s disease (AD) is characterized by marked cognitive and especially mnemonic decline. Microcomputer controlled tests offer a powerful method for assessing these impairments, since precise control over stimulus presentation and responding can be achieved. The recently described CANTAB© (Cambridge Neuropsychological Test Automated Battery) procedure includes a number of visual tasks which can help to pinpoint these deficiencies with accuracy. Using some of the tests available, we describe impairments in nonverbal visual recognition, memory and learning seen in AD.
No takes yet. Share an insight, caveat, or question.
Sahgal et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: